About Sarah
Sarah L. Wicks counsels innovative drug and biologics companies on FDA regulatory and compliance matters that arise in the development and commercialization of new products and indications. These issues regularly include those relating to human subject protections and the conduct of clinical trials, product development strategies, interactions with the FDA, advertising, promotion and labeling, internal investigations and responding to FDA inspection observations and enforcement actions. Ms. Wicks also advises FDA-regulated entities in corporate transactions, offerings and licensing matters.Ms. Wicks is also an adjunct professor at the George Washington University Law School where she coaches teams competing in health law moot court and other FDA and healthcare law related competitions. Ms. Wicks serves on the Committee for the Baltimore Chapter of the Society for Clinical Research Associates (SOCRA) and is a member of Women in Bio and the Food and Drug Law Institute (FDLI).Ms. Wicks originally joined the firm in 2019 and was an associate in the life sciences regulatory and compliance practice of a large international law firm in Washington, D.C. While in law school, Ms. Wicks interned at FDA’s Office of Generic Drugs Policy within the Center for Drug Evaluation and Research and the Office of Legislation within the Office of the Commissioner. She also served as a judicial intern at the United States Court of Federal Claims’ Vaccine Claims/Office of Special Masters.
Sarah L. Wicks counsels innovative drug and biologics companies on FDA regulatory and compliance matters that arise in the development and commercialization of new products and indications. These issues regularly include those relating to human subject protections and the conduct of clinical trials, product development strategies, interactions with the FDA, advertising, promotion and labeling, internal investigations and responding to FDA inspection observations and enforcement actions. Ms. Wicks also advises FDA-regulated entities in corporate transactions, offerings and licensing matters.Ms. Wicks is also an adjunct professor at the George Washington University Law School where she coaches teams competing in health law moot court and other FDA and healthcare law related competitions. Ms. Wicks serves on the Committee for the Baltimore Chapter of the Society for Clinical Research Associates (SOCRA) and is a member of Women in Bio and the Food and Drug Law Institute (FDLI).Ms. Wicks originally joined the firm in 2019 and was an associate in the life sciences regulatory and compliance practice of a large international law firm in Washington, D.C. While in law school, Ms. Wicks interned at FDA’s Office of Generic Drugs Policy within the Center for Drug Evaluation and Research and the Office of Legislation within the Office of the Commissioner. She also served as a judicial intern at the United States Court of Federal Claims’ Vaccine Claims/Office of Special Masters.
Sarah L. Wicks counsels innovative drug and biologics companies on FDA regulatory and compliance matters that arise in the development and commercialization of new products and indications. These issues regularly include those relating to human subject protections and the conduct of clinical trials, product development strategies, interactions with the FDA, advertising, promotion and labeling, internal investigations and responding to FDA inspection observations and enforcement actions. Ms. Wicks also advises FDA-regulated entities in corporate transactions, offerings and licensing matters.
Ms. Wicks is also an adjunct professor at the George Washington University Law School where she coaches teams competing in health law moot court and other FDA and healthcare law related competitions. Ms. Wicks serves on the Committee for the Baltimore Chapter of the Society for Clinical Research Associates (SOCRA) and is a member of Women in Bio and the Food and Drug Law Institute (FDLI).
Ms. Wicks originally joined the firm in 2019 and was an associate in the life sciences regulatory and compliance practice of a large international law firm in Washington, D.C. While in law school, Ms. Wicks interned at FDA’s Office of Generic Drugs Policy within the Center for Drug Evaluation and Research and the Office of Legislation within the Office of the Commissioner. She also served as a judicial intern at the United States Court of Federal Claims’ Vaccine Claims/Office of Special Masters.
